2025 NBA Finals: Thunder and Pacers are the modern blueprint of what winning looks like Videos cannot play due to a network issue. Please check your Internet connection and try again.

Cambridge-based Blueprint Medicines brings a pipeline of experimental immunology treatments and one medicine already on sale for a rare condition known as systemic mastocytosis.

PHOENIX – A long-time leader in iron innovation and performance, today PING introduced the Blueprint S and Blueprint T, two new forged iron models engineered and custom-built for golfers seeking ...

Blueprint is in a lurch after major public outcry stopped the intergovernmental agency's plans to revamp Thomasville Road and adjoining sidewalks in Midtown Tallahassee. Hoping to piggyback on the ...

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

He believes the Blueprint will be further adjusted during next year’s legislative session in 2026. But only slightly. He says the big changes will come in 2027 after next year’s mid-term ...